Transpara
Transpara

8 studies from 5 countries - find out what's new at ECR2021 Read News

Smart AI for early breast cancer detection and diagnosis

We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less invasive.

CE marked and FDA cleared 

READ OUR RESPONSE TO COVID-19 AND HOW TRANSPARA CAN HELP

Improving the way 2D and 3D mammograms are read

With the latest dedicated deep learning AI algorithms for breast cancer detection, Transpara® provides radiologists with clinically proven decision support tools. Transpara is trained on over 1 million trusted mammograms and can help with daily workflow and workload. To find out more, please contact us

Transpara – the world’s first dedicated breast AI decision support solution for 2D and 3D mammography.

  • Commercially available right now. It is CE marked and FDA cleared
  • Multiple independent peer reviewed publications demonstrating improvement in accuracy and consistency 1
  • Proven multivendor compatibility 1

NOT ALL AI IS THE SAME – FIND OUT MORE ABOUT HOW TRANSPARA CAN HELP YOU


1. Published data held on file

Trained on over 1 million images

Use Transpara to:

Focus on early detection

Identify cancers earlier

Begin patient treatment earlier to improve survival rates

Improve mammography reading accuracy

With an improvement in accuracy and reduction in false positives, Transpara aims to minimize unnecessary treatments, patient distress and associated costs

Save time by Improving efficiency

Reduce waiting times for results

Transpara starts analysing mammograms immediately, providing objective information including level of suspicion to help the clinician with diagnosis

Rationalize radiologists’ ever-increasing workload by improving productivity

Radiologists face an ever-increasing workload so there is a need to work smarter whilst maintaining the highest quality levels when interpreting images. Transpara empowers radiologists to prioritise and focus on the most suspicious cases.

The Transpara Process

The Transpara Process
Client scan

Client scan

Client undergoes mammogram

Analyze scan

Analyze scan

Transpara analyses mammogram scan

Reading with Transpara

Reading with Transpara

Radiologist reads with support from Transpara, increasing confidence in decision

Result

Make more accurate and consistent decision

Who is Transpara for?

transpara is for radiologists

Transpara is for Radiologists

 
transpara is for healthcare providers

Transpara is for Healthcare Providers

 

News

Article

AI breast cancer diagnoses may reduce disparity in women’s mortality

Here’s an interesting article from the Dutch Ministry of Foreign Affairs entitled “AI breast cancer diagnoses may reduce disparity in

Read more

Article

How AI “will out-perform humans” in the fight against breast cancer and other diseases

Professor Nico Karssemeijer and Professor Sir Michael Brady formed ScreenPoint Medical seven years ago with the aim of reducing the

Read more

Announcement

ScreenPoint Medical’s Transpara powered by Fusion AI™ platform sets the new benchmark for breast AI.

ScreenPoint Medical BV, Europe’s leading developer of AI systems for breast care has announced the introduction of Transpara powered by

Read more

Clinical evidence

New publication European Radiology – Can artificial intelligence reduce the interval cancer rate in mammography screening?

A new retrospective study from Sweden published in European Radiology https://doi.org/10.1007/s00330-021-07686-3 showed that Transpara AI detected 19% of interval cancer

Read more

Trade shows

Important guide to RSNA 2020

ScreenPoint Medical is proud to support RSNA2020 during this turbulent year due to COVID-19.  On the positive side, Transpara deep

Read more

Announcement

Transpara® breast AI by ScreenPoint Medical reaches major milestone

Transpara, the leading Artificial Intelligence support system for breast cancer screening that uses deep learning algorithms to automatically detect potential

Read more
View more